1-9 of 9
Hideyuki Kuroki
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

An Imbalance in TAZ and YAP Expression in Hepatocellular Carcinoma Confers Cancer Stem Cell–like Behaviors Contributing to Disease Progression

Hiromitsu Hayashi, Takaaki Higashi, Naomi Yokoyama, Takayoshi Kaida, Keita Sakamoto, Yukiko Fukushima, Takatsugu Ishimoto, Hideyuki Kuroki, Hidetoshi Nitta, Daisuke Hashimoto, Akira Chikamoto, Eiji Oki, Toru Beppu, Hideo Baba
Journal: Cancer Research
Cancer Res (2015) 75 (22): 4985–4997.
https://doi.org/10.1158/0008-5472.CAN-15-0291
Published: 15 November 2015
View article titled, An Imbalance in TAZ and YAP Expression in Hepatocellular Carcinoma Confers Cancer Stem Cell–like Behaviors Contributing to Disease Progression
Open the PDF for An Imbalance in TAZ and YAP Expression in Hepatocellular Carcinoma Confers Cancer Stem Cell–like Behaviors Contributing to Disease Progression in another window
Includes: Supplementary data
Journal Articles

Abstract 2700: LSKL peptide inhibits thrombospondin-1-mediated TGF-β signal activation and accelerates liver regeneration after hepatectomy in mice

Hideyuki Kuroki, Hiromitsu Hayashi, Shigeki Nakagawa, Keita Sakamoto, Takaaki Higashi, Hidetoshi Nitta, Daisuke Hashimoto, Akira Chikamoto, Toru Beppu, Hideo Baba
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 2700.
https://doi.org/10.1158/1538-7445.AM2014-2700
Published: 01 October 2014
View article titled, Abstract 2700: LSKL peptide inhibits thrombospondin-1-mediated TGF-β signal activation and accelerates liver regeneration after hepatectomy in mice
Journal Articles

Abstract 3468: Integrin-β6 is required for transforming growth factor (TGF)-β-mediated epithelial-mesenchymal transition (EMT) and promotes the disease progression of intrahepatic cholangiocellular carcinoma

Takaaki Higashi, Hiromitu Hayashi, Hideyuki Kuroki, Shigeki Nakagawa, Keita Sakamoto, Hidetoshi Nitta, Akira Chikamoto, Toru Toru, Hideo Baba
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 3468.
https://doi.org/10.1158/1538-7445.AM2014-3468
Published: 01 October 2014
View article titled, Abstract 3468: Integrin-β6 is required for transforming growth factor (TGF)-β-mediated epithelial-mesenchymal transition (EMT) and promotes the disease progression of intrahepatic cholangiocellular carcinoma
Journal Articles

Abstract 3520: TAZ (WWTR1), a key transcription co-activator of hippo-pathway, promotes hepatocellular carcinoma progression via PI3K/Akt/mTOR pathway

Hiromitsu Hayashi, Hideyuki Kuroki, Shigeki Nakagawa, Takaaki Higashi, Keita Sakamoto, Naomi Yokoyama, Takatoshi Ishiko, Toru Beppu, Hideo Baba
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 3520.
https://doi.org/10.1158/1538-7445.AM2014-3520
Published: 01 October 2014
View article titled, Abstract 3520: TAZ (WWTR1), a key transcription co-activator of hippo-pathway, promotes hepatocellular carcinoma progression via PI3K/Akt/mTOR pathway
Journal Articles

Abstract 5350: Enhancer of zeste homolog 2 (EZH2) promotes progression of cholangiocarcinoma by regulating cell cycle and apoptosis.

Shigeki Nakagawa, Hirohisa Okabe, Yasuo Sakamoto, Hiromitsu Hayashi, Daisuke Hashimoto, Hideyuki Kuroki, Katsunori Imai, Hidetoshi Nitta, Akira Chikamoto, Masayuki Watanabe, Toru Beppu, Hideo Baba
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 5350.
https://doi.org/10.1158/1538-7445.AM2013-5350
Published: 15 April 2013
View article titled, Abstract 5350: Enhancer of zeste homolog 2 (EZH2) promotes progression of cholangiocarcinoma by regulating cell cycle and apoptosis.
Journal Articles

Abstract 5353: EZH2-mediated, but not BMI-1, epigenetic alteration may be associated with the accelerated cell proliferation and malignant step in IPMN.

Hideyuki Kuroki
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 5353.
https://doi.org/10.1158/1538-7445.AM2013-5353
Published: 15 April 2013
View article titled, Abstract 5353: EZH2-mediated, but not BMI-1, epigenetic alteration may be associated with the accelerated cell proliferation and malignant step in IPMN.
Journal Articles

Abstract 1160: Inactivated hippo-pathway as a prognostic biomarker in hepatocellular carcinoma.

Hiromitsu Hayashi, Hideyuki Kuroki, Naomi Yokoyama, Shigeki Nakagawa, Hidetoshi Nitta, Katsunori Imai, Daisuke Hashimoto, Yoshiaki Ikuta, Akira Chikamoto, Toru Beppu, Hideo Baba
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 1160.
https://doi.org/10.1158/1538-7445.AM2013-1160
Published: 15 April 2013
View article titled, Abstract 1160: Inactivated hippo-pathway as a prognostic biomarker in hepatocellular carcinoma.
Journal Articles

CD44s Regulates the TGF-β–Mediated Mesenchymal Phenotype and Is Associated with Poor Prognosis in Patients with Hepatocellular Carcinoma

Kosuke Mima, Hirohisa Okabe, Takatsugu Ishimoto, Hiromitsu Hayashi, Shigeki Nakagawa, Hideyuki Kuroki, Masayuki Watanabe, Toru Beppu, Mayumi Tamada, Osamu Nagano, Hideyuki Saya, Hideo Baba
Journal: Cancer Research
Cancer Res (2012) 72 (13): 3414–3423.
https://doi.org/10.1158/0008-5472.CAN-12-0299
Published: 01 July 2012
View article titled, CD44s Regulates the TGF-β–Mediated Mesenchymal Phenotype and Is Associated with Poor Prognosis in Patients with Hepatocellular Carcinoma
Open the PDF for CD44s Regulates the TGF-β–Mediated Mesenchymal Phenotype and Is Associated with Poor Prognosis in Patients with Hepatocellular Carcinoma in another window
Includes: Supplementary data
Journal Articles

Abstract 1055: Enhancer of Zeste Homologue 2 (EZH2) may relate to progression of intra and extrahepatic cholangiocarcinoma

Shigeki Nakagawa, HIrohisa Okabe, Toru Beppu, Hideyuki Kuroki, Kousuke Mima, Hiromitu Hayashi, Katsunori Imai, Hidetoshi Nitta, Osamu Nakahara, Yoshiaki Ikuta, Akira Chikamoto, Takatoshi Ishiko, Hiroshi Takamori, Hideo Baba
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 1055.
https://doi.org/10.1158/1538-7445.AM2012-1055
Published: 15 April 2012
View article titled, Abstract 1055: Enhancer of Zeste Homologue 2 (EZH2) may relate to progression of intra and extrahepatic cholangiocarcinoma